文献速递神经肌肉病认知障碍与痴呆

肌萎缩侧索硬化-额颞叶痴呆谱系中的脑脊液sAPPβ、YKL-40与NfL

CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum.
PubMed 文献 · Neurology · 2018-10-05

本研究比较额颞叶痴呆(FTD,n=86)、肌萎缩侧索硬化(ALS,n=38)与年龄匹配认知正常对照(n=49)的脑脊液sAPPβ、YKL-40和NfL水平,发现FTD和ALS组YKL-40升高、sAPPβ降低;NfL及NfL:sAPPβ比值与整体认知相关,ALS组YKL-40与进展速率相关并与较短生存独立相关。

要点

  • FTD和ALS组脑脊液YKL-40升高、sAPPβ降低,FTD组sAPPβ及sAPPβ/YKL-40比值最低。
  • 整个ALS-FTD谱系中NfL水平及NfL:sAPPβ比值与整体认知表现相关(r=-0.41,p<0.001;r=-0.44,p<0.001)。
  • ALS组YKL-40与疾病进展速率相关(r=0.51,p=0.001),并与较短生存独立相关。

核心结论

  • sAPPβ、YKL-40和NfL可能成为ALS-FTD临床谱系患者分期和预后评估的有价值工具。

研究设计与样本

  • 横断面研究纳入FTD(n=86)、ALS(n=38)及年龄匹配认知正常对照(n=49),排除具有阿尔茨海默病脑脊液特征的FTD参与者。

主要发现

  • 与对照组相比,FTD和ALS组YKL-40水平升高、sAPPβ水平降低。
  • FTD组sAPPβ水平和sAPPβ/YKL-40比值最低,且sAPPβ及sAPPβ/YKL-40比值与FTD疾病严重程度相关。
  • 整个ALS-FTD谱系中,NfL水平与整体认知表现相关(r=-0.41,p<0.001),NfL:sAPPβ比值与整体认知表现相关(r=-0.44,p<0.001)。
  • ALS组YKL-40与疾病进展速率相关(r=0.51,p=0.001),并与较短生存独立相关。
  • FTD和ALS组sAPPβ/YKL-40比值与额颞叶区域皮质厚度呈正相关。

关键数值与推荐

  • 本研究提供III级证据表明脑脊液sAPPβ、YKL-40和NfL水平有助于评估ALS-FTD连续谱中的额颞叶神经变性和进展速率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the clinical utility of 3 CSF biomarkers along the clinical spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). METHODS: We analyzed 3 CSF biomarkers: the soluble β-fragment of amyloid precursor protein (sAPPβ), YKL-40, and neurofilament light (NfL) in FTD (n = 86), ALS (n = 38), and a group of age-matched cognitively normal controls (n = 49). Participants with FTD with a CSF profile of Alzheimer disease were excluded. We compared cross-sectional biomarker levels between groups, studied their correlation with cognitive and functional scales (global cognitive z score, frontotemporal lobar degeneration Clinical Dementia Rating, revised ALS Functional Rating Scale, and ALS progression rate), survival, and cortical thickness. RESULTS: We found increased levels of YKL-40 and decreased levels of sAPPβ in both FTD and ALS groups compared to controls. The lowest sAPPβ levels and sAPPβ/YKL-40 ratio were found in the FTD group. In FTD, sAPPβ and the sAPPβ/YKL-40 ratio correlated with the disease severity. In the whole ALS-FTD spectrum, NfL levels and the NfL:sAPPβ ratio correlated with global cognitive performance (r = -0.41, p < 0.001 and r = -0.44, p < 0.001, respectively). In the ALS group, YKL-40 correlated with disease progression rate (r = 0.51, p = 0.001) and was independently associated with shorter survival. In both FTD and ALS groups, the sAPPβ/YKL-40 ratio showed a positive correlation with cortical thickness in frontotemporal regions. CONCLUSIONS: sAPPβ, YKL-40, and NfL could represent valuable tools for the staging and prognosis of patients within the ALS-FTD clinical spectrum. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that CSF levels of sAPPβ, YKL-40, and NfL are useful to assess frontotemporal neurodegeneration and the progression rate in the ALS-FTD continuum.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Illán-Gala I, Alcolea D, Montal V, et al. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum. Neurology. 2018. PMID: 30291183. doi:10.1212/WNL.0000000000006383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。